NCT06168604 · RECRUITING

Evaluating the Efficacy of the Pain Identification and Communication Toolkit

This trial is testing a caregiver training program called PICT — the Pain Identification and Communication Toolkit. It teaches family caregivers how to spot signs of pain in a loved one with dementia, and how to communicate that pain clearly to medical providers. It is a behavioral study, not a drug trial, comparing PICT against a general health promotion program to see which better helps caregivers identify and report pain.

Eligibility criteria

CAREGIVER PARTICIPANTS
Inclusion Criteria:
1. Age 21 or older
2. Any gender
3. English speaking
4. Cognitively intact (BOMC ≤10)
5. Provides care to a community-dwelling adult with dementia or cognitive impairment who also has a pain diagnosis
6. Care recipient is not enrolled in hospice
7. Visits the care recipient at least weekly
8. Accessible by telephone
Exclusion Criteria:
1. Paid caregiver
2. Age 20 or younger
3. Non-English speaking
4. Cognitively impaired
5. Does not provide care to a person with dementia or cognitive impairment who also has a pain diagnosis
6. Currently enrolled in hospice
7. The patient to whom the caregiver provides assistance is enrolled in hospice
8. Visits care recipient less than weekly
9. Not accessible by telephone.
PATIENT PARTICIPANTS
Inclusion Criteria:
1. Residing in community settings
2. Record of dementia or cognitive impairment
3. Diagnosis of pain
4. Responsive to environment
5. No terminal illness with life expectancy \<6 months
6. Not in active cancer treatment
Exclusion Criteria:
1. Lives in a residential facility (such as a nursing home or assisted living)
2. Enrolled in hospice
3. No dementia or cognitive impairment
4. Unresponsive to environment
5. Has terminal illness with life expectancy \<6 months
6. Are in active cancer treatment

The sponsor's own eligibility wording, lightly reformatted. The study team makes the final eligibility decision — worth discussing with your doctor.

Eligibility criteria as of 2026-02-12

View full record on ClinicalTrials.gov

All APOE4 clinical trials